loading page

A comparison of tamsulosin and silodosin versus tadalafil in medical expulsive therapy for distal ureteral stone in men: a prospective study
  • +2
  • Metin Gur,
  • Suleyman Tumer Caliskan,
  • Muhammet Bahaettin Ulu,
  • Ekrem Akdeniz,
  • Kemal Ozturk
Metin Gur
Gazi Hospital
Author Profile
Suleyman Tumer Caliskan
Gazi Hospital
Author Profile
Muhammet Bahaettin Ulu
Gazi Hospital
Author Profile
Ekrem Akdeniz
Gazi Hospital
Author Profile
Kemal Ozturk
Gazi Hospital
Author Profile

Abstract

Objectives: To evaluate the efficacy of tamsulosin, silodosin, and tadalafil as medical expulsive therapy for distal ureteral stones in men. Methods: Adult males meeting the inclusion criteria were randomized into one of four treatment arms - dexketoprofen (control group), tamsulosin (Group 1), silodosin (Group 2), and tadalafil (Group 3). The stone expulsion rate after four weeks represented the primary endpoint, while the stone expulsion rate at the end of the study and the incidence of adverse events constituted secondary endpoints. Clinical findings were compared between all four drug groups. Results: No statistically significant difference was observed among the groups in terms of age, body mass index, stone futures, expulsion time, pain episodes, or total analgesic use. Expulsion rates in the fourth week were 42.5%, 80%, 82.5%, and 75%, respectively. The stone expulsion rates in groups 1, 2, and 3 were significantly higher than in the control group (p < 0.001). However, the differences between groups 1, 2, and 3 were not statistically significant. No serious adverse effects were observed during the study period. Conclusion: The study results showed a higher expulsion rate in male patients using tamsulosin, silodosin and tadalafil for distal ureteral stones, but no significant superiority between these. All three are safe, effective, and well-tolerated, causing minimal side-effects.

Peer review status:UNDER REVIEW

11 Jan 2021Submitted to International Journal of Clinical Practice
12 Jan 2021Assigned to Editor
12 Jan 2021Submission Checks Completed
13 Jan 2021Reviewer(s) Assigned
16 Jan 2021Review(s) Completed, Editorial Evaluation Pending